Related Experiment Videos
Beta 2-microglobulin serum levels in infectious mononucleosis in childhood
Abstract:
A material of fifteen children aged 10 months to 15 years with infectious mononucleosis (IM) was investigated. The diagnosis was established by demonstration of Epstein-Barr virus (EBV) specific IgM antibodies. The serum concentrations of beta 2-microglobulin (beta 2-m) were significantly increased (p less than 0.01) in the first sample after onset of disease, compared to control groups of children with other infectious diseases and children without diseases. The serum concentration of beta 2-m decreased towards normal range within 3 weeks- 3 months. During the same period, IgM antibodies of EBV decreased to unmeasurable levels, and the IgG titers were almost constant. Serum beta -2m may be a parameter of value in the diagnosis of infectious mononucleosis in childhood, replacing tests for heterophile antibodies (Emni test and Paul-Bunnell test) which are often negative in children suffering from a primary EBV infection, or it may be used for assessment of disease activity.
Insights
Serum beta 2-microglobulin (beta 2-m) levels are elevated in children with infectious mononucleosis (IM). These levels decrease over time, suggesting beta 2-m as a diagnostic marker for childhood IM.
Area of Science:
- Pediatrics
- Immunology
- Virology
Background:
- Infectious mononucleosis (IM) in children is often caused by Epstein-Barr virus (EBV).
- Diagnosing primary EBV infection in children can be challenging due to often negative heterophile antibody tests.
- Biomarkers are needed for accurate diagnosis and monitoring of childhood IM.
Purpose of the Study:
- To investigate the utility of serum beta 2-microglobulin (beta 2-m) as a diagnostic marker for infectious mononucleosis (IM) in children.
- To assess the correlation between beta 2-m levels and disease activity in pediatric IM patients.
Main Methods:
- Studied a cohort of fifteen children diagnosed with IM based on Epstein-Barr virus (EBV) specific IgM antibodies.
- Measured serum beta 2-microglobulin (beta 2-m) concentrations in patients and compared them to control groups.
- Monitored beta 2-m levels, EBV IgM, and EBV IgG titers over a period of 3 weeks to 3 months post-onset.
Main Results:
- Serum beta 2-m concentrations were significantly elevated (p < 0.01) in children with IM compared to controls.
- Beta 2-m levels normalized within 3 weeks to 3 months, correlating with decreasing EBV IgM titers.
- EBV IgG titers remained relatively constant during the study period.
Conclusions:
- Serum beta 2-m is a potentially valuable diagnostic parameter for infectious mononucleosis in childhood.
- Beta 2-m may serve as an alternative to heterophile antibody tests, which are frequently negative in pediatric primary EBV infections.
- Monitoring serum beta 2-m levels could aid in assessing disease activity in pediatric IM.